References
- Chinese Pharmacopoeia Commission. 2010. Pharmacopoeia of the People’s Republic of China. 1st ed. Beijing: China Medical Science Press.
- Cossard G, Sannier J, Sauquet H, Damerval C, Craene LR, Jabbour F, Nadot S. 2016. Subfamilial and tribal relationships of Ranunculaceae: evidence from eight molecular markers. Plant Syst Evol. 302:419–431.
- Dierckxsens N, Mardulyn P, Smits G. 2017. NOVOPlasty: de novo assembly of organelle genomes from whole genome data. Nucleic Acids Res. 45:e18.
- Miller MA, Pfeiffer W, Schwartz T. 2010. Creating the CIPRES science gateway for inference of large phylogenetic trees. Gateway Computing Environments Workshop (GCE); New Orleans, LA. p. 1–8.
- Ronquist F, Huelsenbeck JP. 2003. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 19:1572–1574.
- Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics. 30:1312–1313.
- Zhang L, Zhang XP. 2004. The investigation and protection of the endangered plant of Coptis chinensis var. brevisepala in Anhui Province. J Plant Resour Environ. 13:44–48.
- Zhang L, Zhang XP. 2005. Population characteristics of Coptis chinensis var. brevisepala in Anhui Province and its endangering mechanism. J Appl Ecol. 16:1394–1398.
- Zhang YY, Dong JX, Feng Y, Wang ZS, Li P. 2018. The first complete chloroplast genome of Coptis quinquesecta, a critically endangered medicinal plant in China. Mitochondrial DNA B: Resour. 3:370–372.